Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2005
12/15/2005WO2005118558A2 Pyrimidine compounds and use thereof
12/15/2005WO2005118556A1 Propane-1,3-dione derivative or its salt
12/15/2005WO2005118555A1 Dipeptidyl peptidase inhibitors
12/15/2005WO2005118548A1 Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
12/15/2005WO2005118547A1 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
12/15/2005WO2005118544A2 Cycloalkyl substituted pyrimidinediamine compounds and their uses
12/15/2005WO2005118542A1 Glucagon receptor antagonists, preparation and therapeutic uses
12/15/2005WO2005118539A1 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor
12/15/2005WO2005118538A2 Arylsulfonamides and uses as hydroxysteroid dehydrogenase
12/15/2005WO2005118535A1 Substituted pyrrolidine-2-ones
12/15/2005WO2005117908A2 Triheterocyclic compounds compositions, and methods for treating cancer or viral diseases
12/15/2005WO2005117883A1 Modulators of muscarinic receptors
12/15/2005WO2005117882A2 Hydroxamic acid derivatives as metalloprotease inhibitors
12/15/2005WO2005117876A1 Dual small molecule inhibitors of cancer and angiogenesis
12/15/2005WO2005117867A2 Monocyclic heterocycles as kinase inhibitors
12/15/2005WO2005117865A1 Naphthaline derivatives useful as histamine-3-receptor ligands
12/15/2005WO2005097768A3 Novel gamma secretase inhibitors
12/15/2005WO2005075455A3 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
12/15/2005WO2005060665A3 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
12/15/2005WO2005060571A3 Antiprotozoal imidazopyridine compounds
12/15/2005WO2005044195A3 Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
12/15/2005WO2004098590A8 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl) eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
12/15/2005US20050277686 Benzimidazole compounds for regulating IgE
12/15/2005US20050277685 peroxisome proliferator activated receptor agonist such as (2R)-2-(3-{[3-(4-chlorophenoxy)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl]methyl}phenoxy)butanoic acid, used for treatment and control of metabilic disorders
12/15/2005US20050277683 Novel pyrrolidine bicyclic compounds and its derivatives, compositions and methods of use
12/15/2005US20050277678 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent
12/15/2005US20050277674 opioid receptor ligands such as {4-[3-(1H-indol-3-yl)-pyrrolidine-1-yl]-1-phenyl-cyclohexyl}-dimethylamine dihydrochloride salt, used as analgesics
12/15/2005US20050277673 such as 4-{[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}tetrahydro-2H-pyran-4-carboxylic acid; serotonin receptor agonist; antidepressant, anxiolytic agent, analgesic, cognition activator; less toxicity, good absorption, and metabolic stability
12/15/2005US20050277672 such as 1-{[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}cyclopentanecarboxylic acid; serotonin receptor agonist; antidepressant, anxiolytic agent, analgesic, cognition activator; less toxicity, good absorption, and metabolic stability
12/15/2005US20050277671 Benzimidazolone carboxylic acid derivatives
12/15/2005US20050277670 Chemokine receptor binding compounds
12/15/2005US20050277668 viricide, antiinflammatory agent; autoimmune diseases; protective effects against infection of target cells by a human immunodeficiency virus (HIV); 6-Chloro-N-((R)-3-{4-[(4-methoxy-phenyl)-(4-methyl-pyridin-3-ylmethyl)-amino]-piperidin-1-yl}-butyl)-2,4-dimethyl-nicotinamide
12/15/2005US20050277663 3-Aryl-3-hydroxy-and 3-aryl-3-oxopropionic acid esters as fungicides
12/15/2005US20050277660 Novel tetrahydroquinoline derivatives
12/15/2005US20050277659 Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as ORL1-receptor antagonists
12/15/2005US20050277654 4,5-Disubstituted-2-aryl pyrimidines
12/15/2005US20050277653 Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
12/15/2005US20050277652 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide
12/15/2005US20050277649 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors; potentiation; diabetes and obesity; 2-(4-{4-[1-(6-chloro-pyridin-3-yl)cyclopropylmethyl]-2-(R)-methyl-piperazine-1-sulfonyl}phenyl)-1,1,1-trifluoro-propan-2-ol
12/15/2005US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function
12/15/2005US20050277642 Pyrimidine kinase inhibitors
12/15/2005US20050277640 Pyrimidine derivatives for treatment of hyperproliferative disorders
12/15/2005US20050277638 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
12/15/2005US20050277637 Arylindenopyridines and related therapeutic and prophylactic methods
12/15/2005US20050277631 Vanilloid receptor ligands and their use in treatments
12/15/2005DE4332964B4 Verfahren zur Herstellung von aromatischen Polyetherketonen A process for the preparation of aromatic polyetherketones
12/15/2005DE19963607B4 Verfahren zur Herstellung von 4-(Heteroaryl-methyl) halogen-1(2H)-phthalazinonen Process for the preparation of 4- (heteroaryl-methyl) halo-1 (2H) -phthalazinonen
12/15/2005DE102004026026A1 New 2-(hetero)aryl-tetrahydroquinoline derivatives and 1,2,3,4-tetrahydro-1,5-naphthyridine derivatives are mitotic motor protein Eg5 inhibitors used as anticancer agents for treating carcinoma or leukemia
12/15/2005DE102004024773A1 Substituierte 2,5-Diaminomethyl-1H-pyrrole Substituted 2,5-diaminomethyl-1H-pyrroles
12/15/2005CA2778894A1 Compounds for measuring nitroreductase enzyme activity
12/15/2005CA2569238A1 Monoamine reuptake inhibitor
12/15/2005CA2568652A1 Process for the preparation of pyridin-2-ylmethylsulphinyl-1h-benzimidazol compounds
12/15/2005CA2568622A1 Dual small molecule inhibitors of cancer and angiogenesis
12/15/2005CA2568524A1 Modulators of muscarinic receptors
12/15/2005CA2567832A1 Quinazoline derivatives as erbb receptor tyrosine kinases
12/15/2005CA2567489A1 Pyridin-2-one compounds and their use as modulators of the dopamine d3 receptor
12/15/2005CA2567356A1 Magnesium complexes of s-omeprazole
12/15/2005CA2566594A1 Butyrylcholinesterase selective inhibitors
12/15/2005CA2566531A1 Cycloalkyl substituted pyrimidinediamine compounds and their uses
12/15/2005CA2566187A1 Mercaptoimidazoles as ccr2 receptor antagonists
12/15/2005CA2565689A1 Substituted pyrrolidine-2-ones
12/15/2005CA2565280A1 Mercaptoimidazoles as ccr2 receptor antagonists
12/15/2005CA2563831A1 Monocyclic heterocycles as kinase inhibitors
12/15/2005CA2561858A1 Arylsulfonamides and uses related thereto
12/14/2005EP1604988A1 Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals
12/14/2005EP1604982A1 Intermediates for the preparation of piperidine derivatives useful as modulators of chemokine receptor activity
12/14/2005EP1604979A1 2-oxo-1-pyrrolidine derivative and its pharmaceutical uses
12/14/2005EP1604653A1 Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder
12/14/2005EP1603913A1 Solvent-free process for the preparation of diketopyrrolopyrrole derivatives
12/14/2005EP1603912A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
12/14/2005EP1603911A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
12/14/2005EP1603899A1 Heterocyclic urea derivatives for the treatment of pain
12/14/2005EP1603898A2 Chemical derivatives binding very specifically with g-quadruplex dna structures and use thereof as a specific anti-cancer agent
12/14/2005EP1603897A1 Pyrazole compounds useful in the treatment of inflammation
12/14/2005EP1603896A2 Cxcr3 antagonists
12/14/2005EP1603895A1 Substituted benzoylureidopyridyl-piperidine and -pyrrolidine carboxylic acid derivatives, method for the production thereof and the use thereof
12/14/2005EP1603886A1 4-substituted-5-cyano-1h-pyrimidin-6-(thi)ones as gsk-3 inhibitors
12/14/2005EP1603885A1 Fused tri and tetra-cyclic pyrazole kinase inhibitors
12/14/2005EP1603884A2 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-ii receptor antagonists.
12/14/2005EP1603883A2 Quinoline-derived amide modulators of vanilloid vr1 receptor
12/14/2005EP1603880A1 Quinolinone/benzoxazinone derivatives and uses thereof
12/14/2005EP1603879A2 Substituted pyridine derivatives useful in the treatment of cancer and other disorders
12/14/2005EP1603874A2 G-lactam derivatives as prostaglandin agonists
12/14/2005EP1603572A1 Lactam-containing cyclic diamines and derivatives as factor xa inhibitors
12/14/2005EP1603570A2 Aminoheteroaryl compounds as protein kinase inhibitors
12/14/2005EP1603562A2 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
12/14/2005EP1427709B1 3-substituted-4-pyrimidone derivatives
12/14/2005EP1326858B1 Piperidine compounds as anti-allergic
12/14/2005EP1224165B1 Novel compounds
12/14/2005EP1222175B1 4,5-disubstituted-2-aminopyrimidines
12/14/2005EP1200411B1 Process for synthesis of heteroaryl-substituted urea compounds
12/14/2005EP1177189B1 Solvates of pymetrozine
12/14/2005EP1121355B1 Quinoline derivatives and their use as antibacterial agents
12/14/2005EP1119562B1 2,3-dihydro-1h-isoindole derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
12/14/2005EP1112255B1 4,4-biarylpiperidine derivatives with opioid receptor activity
12/14/2005EP1043976B1 Oral pharmaceutical extended release dosage form
12/14/2005EP1007047B1 Use of mizolastine for preparing a medicine for treating inflammation
12/14/2005CN1708560A Beta-isoindigo coloring agent
12/14/2005CN1708494A Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds
12/14/2005CN1708493A Selected CGRP antagonists, method for production and use thereof as medicament
1 ... 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 ... 1080